Sloane & Company Expands its Healthcare Practice with the Appointment of Managing Director Leslie Wheeler
October 15, 2024 08:00 ET
|
Sloane & Company
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Sloane & Company, a strategic communications firm at the intersection of valuation and reputation, announces the appointment of Leslie Wheeler as a...
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
October 15, 2024 07:00 ET
|
Avacta Group
Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024 –...
Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer
October 15, 2024 02:00 ET
|
Avacta Group
Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024...
mRNA Cancer Vaccines and Therapeutics Research Report 2024 with Long-term Forecasts to 2028 and 2033: Personalized Medicine and Multivalent mRNA Vaccines Lead the Way
October 14, 2024 11:48 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "mRNA Cancer Vaccines and Therapeutics Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The mRNA cancer vaccines and...
Multiple System Atrophy (MSA) Market is expected to reach US$ 202.3 Million by 2031, Report by CoherentMI
October 14, 2024 11:03 ET
|
CMI
Burlingame, Oct. 14, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, Multiple System Atrophy (MSA) Market is estimated to value at US$ 148.1 Million in the year 2024, and is...
Global Cancer Gene Therapy Market Set for Significant Growth, Projected to Reach USD 3,142.2 Million by 2034 Driven by Personalized Medicine and Targeted Therapies | Future Market Insights, Inc.
October 14, 2024 09:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The global cancer gene therapy market is poised for robust expansion, with sales projected to rise from USD 1,822.2 million in 2024 to an impressive...
Bispecific Antibody Drug Conjugates Market Opportunity Outlook 2024-2029: China Leads Over 35 Candidates, Key Companies Pioneering BsADC are Amgen, Innovent Biologics, AstraZeneca
October 14, 2024 05:52 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029" report has been added to...
Diagnostic Testing Market Size to Surpass USD 272.98 Bn by 2034
October 11, 2024 10:00 ET
|
Precedence Research
Ottawa, Oct. 11, 2024 (GLOBE NEWSWIRE) -- According to Precedence Research, the global diagnostic testing market size is anticipated to reach around USD 264.12 billion by 2033 increasing from USD...
Cancer Vaccines Market Forecasts from 2024 to 2029: Lung and Breast Cancer Remain Key Targets, FDA Approvals for HPV and HBV Vaccines Boost Expansion
October 11, 2024 06:49 ET
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccines Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global cancer vaccine...
COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place
October 11, 2024 06:35 ET
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...